CERG Ceres (MM)

Ceres Group, Inc. (NASDAQ:CERG) today announced that its president and chief executive officer, Tom Kilian, will present at the Friedman, Billings, Ramsey & Co., Inc. (FBR) 12th Annual Investor Conference on Wednesday, November 30, 2005 at 8:30 a.m. ET in New York City at the Grand Hyatt New York. Investors will be able to access the presentation via the FBR website at www.fbr.com. The direct link to the registration page is http://www.wsw.com/webcast/fbr13/cerg/. Following the live webcast, a replay of the presentation will be available for 90 days. Mr. Kilian's presentation will also be available on the Ceres website at www.ceresgp.com. About Ceres Group Ceres Group, Inc., through its insurance subsidiaries, provides a wide array of health and life insurance products through two primary business segments. Ceres' Medical Segment includes major medical health insurance for individuals, families, associations and small businesses. The Senior Segment includes senior health, life and annuity products for Americans age 55 and over. To help control medical costs, Ceres also provides medical cost management services to its insureds. Ceres' nationwide distribution channels include independent and career agents, as well as electronic distribution systems. Ceres is included in the Russell 3000(R) Index. For more information, visit www.ceresgp.com. This news release contains certain forward-looking statements with respect to the financial condition, results of operations and business of the company. Forward-looking statements are statements other than historical information or statements of current condition. In light of the risks and uncertainties inherent in all future projections, the inclusion of forward-looking statements herein should not be regarded as representation by the company or any other person that the objectives or plans of the company will be achieved. Many factors could cause actual results to differ materially from those contemplated by such forward-looking statements, including, among others, failure to accurately predict loss ratios and improvements in our business, business conditions and competition in the healthcare industry, the failure to successfully implement the business plans (including the company's growth strategy) for the company and its subsidiaries, failure to accurately predict claims liabilities, ability to institute necessary rate increases, ability to develop, market and administer new and competitive products, developments in healthcare reform and other regulatory issues (including failure to meet statutory capital requirements), rising healthcare costs, adverse outcomes in litigation and related matters, failure to comply with financial and other covenants in our loan agreement, and performance of our reinsurers. This review of important factors should not be construed as exhaustive. Investors and others should refer to Ceres' filings with the Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2004, and its quarterly reports on Form 10-Q and other periodic filings, for a description of the foregoing and other factors. Ceres undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.